罗亚平, 李方. 放射性核素诊疗现状与未来展望[J]. 协和医学杂志, 2023, 14(4): 669-672. DOI: 10.12290/xhyxzz.2023-0236
引用本文: 罗亚平, 李方. 放射性核素诊疗现状与未来展望[J]. 协和医学杂志, 2023, 14(4): 669-672. DOI: 10.12290/xhyxzz.2023-0236
LUO Yaping, LI Fang. Current Status and Future Prospects of Theranostics with Radiopharmaceuticals[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 669-672. DOI: 10.12290/xhyxzz.2023-0236
Citation: LUO Yaping, LI Fang. Current Status and Future Prospects of Theranostics with Radiopharmaceuticals[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 669-672. DOI: 10.12290/xhyxzz.2023-0236

放射性核素诊疗现状与未来展望

Current Status and Future Prospects of Theranostics with Radiopharmaceuticals

  • 摘要: 放射性核素诊疗(即核医学技术)是利用放射性核素进行疾病诊断和治疗的技术,其已历经百余年发展历程。得益于设备和放射性药物的进步、临床需求的增加、国家政策的支持以及全球化合作的开启,核医学技术得以快速发展。时至今日,核医学技术已成为一种广泛应用于影像诊断及治疗的技术,在临床中发挥重要且独特的价值。未来,核医学仍将在影像诊断、放射性核素治疗、人工智能领域继续蓬勃发展,并将取得更大的进步。

     

    Abstract: Nuclear medicine is a novel technique of theranostics that uses radiopharmaceuticals. Nuclear medicine dated back to a century ago. Owing to the development of nuclear medicine devices and radiopharmaceuticals, increasing clinical demand, government support, and global cooperations, nuclear medicine has witnessed a rapid development. Nowadays, nuclear medicine has played an important and unique role in diagnosis and therapy. There are opportunities and challenges in future development of nuclear medicine, and more progress will be made in nuclear medicine imaging, radionuclide therapy, and artificial intelligence.

     

/

返回文章
返回